Comparison of an extended-release formulation of granisetron (APF530) versus palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately or highly emetogenic chemotherapy: results of a prospective, randomized, double-blind, noninferiority phase 3 trial

被引：0
|
作者：
Harry Raftopoulos
William Cooper
Erin O’Boyle
Nashat Gabrail
Ralph Boccia
Richard J. Gralla
机构：
[1] Hofstra North Shore-LIJ School of Medicine,Albert Einstein College of Medicine
[2] TFS International,undefined
[3] FibroGen,undefined
[4] Inc.,undefined
[5] Gabrail Cancer Center,undefined
[6] Center for Cancer and Blood Disorders,undefined
[7] Jacobi Medical Center,undefined
来源：
Supportive Care in Cancer | 2015年 / 23卷
关键词：
Cancer; Chemotherapy-induced nausea and vomiting (CINV); Extended-release; Granisetron; Subcutaneous; APF530;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：723 / 732
页数：9
相关论文
共 50 条
  • [11] Pharmacokinetics, safety, and efficacy of APF530 (extended-release granisetron) in patients receiving moderately or highly emetogenic chemotherapy: results of two Phase II trials
    Gabrail, Nashat
    Yanagihara, Ronald
    Spaczynski, Marek
    Cooper, William
    O'Boyle, Erin
    Smith, Carrie
    Boccia, Ralph
    CANCER MANAGEMENT AND RESEARCH, 2015, 7 : 83 - 92
  • [12] Efficacy of oral palonosetron compared to intravenous palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: a phase 3 trial
    Ralph Boccia
    Steven Grunberg
    Edwin Franco-Gonzales
    Edward Rubenstein
    Daniel Voisin
    Supportive Care in Cancer, 2013, 21 : 1453 - 1460
  • [13] Efficacy of oral palonosetron compared to intravenous palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: a phase 3 trial
    Boccia, Ralph
    Grunberg, Steven
    Franco-Gonzales, Edwin
    Rubenstein, Edward
    Voisin, Daniel
    SUPPORTIVE CARE IN CANCER, 2013, 21 (05) : 1453 - 1460
  • [14] Phase 3 trial of APF530 versus palonosetron (PALO) in preventing chemotherapy-induced nausea and vomiting (CINV): Efficacy in breast cancer patients (pts) receiving moderately (MEC) or highly (HEC) emetogenic chemotherapy.
    Boccia, Ralph V.
    Cooper, William
    O'Boyle, Erin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [15] A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy
    Aapro, M. S.
    Grunberg, S. M.
    Manikhas, G. M.
    Olivares, G.
    Suarez, T.
    Tjulandin, S. A.
    Bertoli, L. F.
    Yunus, F.
    Morrica, B.
    Lordick, F.
    Macciocchi, A.
    ANNALS OF ONCOLOGY, 2006, 17 (09) : 1441 - 1449
  • [16] ONDANSETRON VERSUS GRANISETRON IN THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL
    GEBBIA, V
    CANNATA, G
    TESTA, A
    CURTO, G
    VALENZA, R
    CIPOLLA, C
    LATTERI, MA
    GEBBIA, N
    CANCER, 1994, 74 (07) : 1945 - 1952
  • [17] Slow-release granisetron (APF530) versus palonosetron for chemotherapy-induced nausea/vomiting: analysis by American Society of Clinical Oncology emetogenicity criteria
    Raftopoulos, Harry
    Boccia, Ralph
    Cooper, William
    O'Boyle, Erin
    Gralla, Richard J.
    FUTURE ONCOLOGY, 2015, 11 (18) : 2541 - 2551
  • [18] Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study
    Ralph V. Boccia
    Lucio N. Gordan
    Gemma Clark
    Julian D. Howell
    Steven M. Grunberg
    Supportive Care in Cancer, 2011, 19 : 1609 - 1617
  • [19] Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study
    Boccia, Ralph V.
    Gordan, Lucio N.
    Clark, Gemma
    Howell, Julian D.
    Grunberg, Steven M.
    SUPPORTIVE CARE IN CANCER, 2011, 19 (10) : 1609 - 1617
  • [20] Transdermal granisetron for the prevention of nausea and vomiting following moderately or highly emetogenic chemotherapy in Chinese patients: a randomized, double-blind, phase III study
    Yang, Liu-Qing
    Sun, Xin-Chen
    Qin, Shu-Kui
    Chen, Ying-Xia
    Zhang, He-Long
    Cheng, Ying
    Chen, Zhen-Dong
    Shi, Jian-Hua
    Wu, Qiong
    Bai, Yu-Xian
    Han, Bao-Hui
    Liu, Wei
    Ouyang, Xue-Nong
    Liu, Ji-Wei
    Zhang, Zhi-Hui
    Li, Yong-Qiang
    Xu, Jian-Ming
    Yu, Shi-Ying
    CHINESE CLINICAL ONCOLOGY, 2016, 5 (06)
12345